UMR 1319 INSPIIRE, Université de Lorraine, Inserm, F-54000 Nancy, France.
UMR 1319 INSPIIRE, Université de Lorraine, Inserm, F-54000 Nancy, France
BMJ Open. 2024 Sep 12;14(9):e083090. doi: 10.1136/bmjopen-2023-083090.
The short-term effectiveness of the PRomotion de l'ALIMentation et de l'Activité Physique-INÈgalités de Santé' (PRALIMAP-INÈS) intervention to reduce social inequalities in overweight and obesity management among adolescents between 2012 and 2015 was demonstrated. This longitudinal mixed-methods study is a 10-year postintervention follow-up of the PRALIMAP-INÈS intervention with the aim of investigating social, economic, educational and health (especially weight) trajectories from adolescence to young adulthood.
Among adolescents enrolled in PRALIMAP-INÈS (n=1419), we estimate the number of participants to be 852. Adolescents who were included in the PRALIMAP-INÈS intervention will be contacted 10 years later and invited to participate in a follow-up visit. Participants will self-report their sociodemographic characteristics, body image perceptions, overweight/obesity care pathway, lifestyle and dietary behaviours and attitudes, psychological health and experience of the PRALIMAP-INÈS intervention. A check-up visit will be scheduled by a clinical research nurse to record waist circumference and weight and height for body mass index calculation and to construct the healthcare pathway from adolescence to young adulthood. 40 participants will be invited to participate in a semistructured interview conducted by a sociologist to deepen the understanding of trajectories regarding social aspects that are likely to influence health behaviours in participants.
The PRALIMAP-CINeCO trial was approved by French Persons Protection Committee (no. 2021-A00949-32) and a conformity declaration was made with French National Commission for Data Protection and Liberties. Results will be presented at conferences and published in international peer-reviewed journals.
NCT05386017; Pre-results.
2012 年至 2015 年间，“促进饮食与身体活动以减少健康不平等”（PRALIMAP-INÈS）干预措施在减少青少年超重和肥胖管理方面的短期效果得到了证明。本纵向混合方法研究是 PRALIMAP-INÈS 干预措施的 10 年干预后随访，旨在调查青少年到成年早期的社会、经济、教育和健康（特别是体重）轨迹。
在参加 PRALIMAP-INÈS 的青少年中（n=1419），我们估计参与者人数为 852 人。将联系包括在 PRALIMAP-INÈS 干预中的青少年，10 年后邀请他们参加随访访问。参与者将自我报告他们的社会人口特征、身体意象感知、超重/肥胖护理途径、生活方式和饮食行为和态度、心理健康以及对 PRALIMAP-INÈS 干预的体验。临床研究护士将安排一次体检，记录腰围和体重，以及身高以计算体重指数，并构建从青少年到成年早期的医疗保健途径。将邀请 40 名参与者参加由社会学家进行的半结构式访谈，以深入了解可能影响参与者健康行为的社会方面的轨迹。
PRALIMAP-CINeCO 试验已获得法国人员保护委员会的批准（编号 2021-A00949-32），并已向法国国家数据保护与自由委员会作出一致性声明。结果将在会议上展示，并发表在国际同行评议期刊上。
NCT05386017；预结果。
